Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.768
-0.0320 (-4.00%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Jan 24, 2024 $0.712 $0.720 $0.680 $0.718 283 753
Jan 23, 2024 $0.689 $0.730 $0.670 $0.700 382 284
Jan 22, 2024 $0.660 $0.684 $0.650 $0.665 675 256
Jan 19, 2024 $0.690 $0.690 $0.639 $0.660 525 038
Jan 18, 2024 $0.703 $0.720 $0.640 $0.666 667 103
Jan 17, 2024 $0.683 $0.702 $0.650 $0.699 651 229
Jan 16, 2024 $0.765 $0.782 $0.690 $0.695 640 680
Jan 12, 2024 $0.785 $0.796 $0.751 $0.765 531 124
Jan 11, 2024 $0.83 $0.84 $0.768 $0.782 690 566
Jan 10, 2024 $0.790 $0.83 $0.760 $0.81 667 252
Jan 09, 2024 $0.796 $0.796 $0.751 $0.770 455 657
Jan 08, 2024 $0.741 $0.796 $0.741 $0.779 825 779
Jan 05, 2024 $0.750 $0.765 $0.723 $0.745 574 613
Jan 04, 2024 $0.80 $0.80 $0.741 $0.752 967 220
Jan 03, 2024 $0.83 $0.83 $0.771 $0.81 607 827
Jan 02, 2024 $0.760 $0.85 $0.750 $0.83 1 016 224
Dec 29, 2023 $0.737 $0.82 $0.725 $0.81 1 237 316
Dec 28, 2023 $0.790 $0.82 $0.730 $0.750 1 632 785
Dec 27, 2023 $0.780 $0.86 $0.780 $0.82 2 306 220
Dec 26, 2023 $0.701 $0.83 $0.670 $0.80 3 786 181
Dec 22, 2023 $0.83 $0.89 $0.710 $0.720 8 881 533
Dec 21, 2023 $1.01 $1.13 $0.82 $0.86 103 878 980
Dec 20, 2023 $0.550 $0.580 $0.550 $0.565 385 094
Dec 19, 2023 $0.580 $0.603 $0.540 $0.558 764 447
Dec 18, 2023 $0.640 $0.660 $0.563 $0.565 665 557
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT